These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30344194)

  • 41. Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study.
    Ma A; Liu F; Wang C; Liang K; Yan F; Hou X; Liu J; Chen L
    Int Urol Nephrol; 2018 Dec; 50(12):2239-2244. PubMed ID: 30182294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; So WY; Ma RC; Kong AP; Ozaki R; Ng VS; Yu LW; Lau WW; Yang X; Chow FC; Chan JC; Tong PC;
    Diabetes Care; 2008 Dec; 31(12):2357-61. PubMed ID: 18835954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between obesity and risk of chronic kidney disease: A nationwide Cohort study in Taiwan.
    Lai YJ; Hu HY; Lee YL; Ku PW; Yen YF; Chu D
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):1008-1014. PubMed ID: 28986076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic Steatosis Index and Chronic Kidney Disease among Middle-Aged Individuals: A Large-Scale Study in Japan.
    Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Sakamoto K; Azuma M; Kokaze A
    Dis Markers; 2021; 2021():9941834. PubMed ID: 34211614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD).
    Ito K; Maeda T; Tada K; Takahashi K; Yasuno T; Masutani K; Mukoubara S; Arima H; Nakashima H
    Clin Exp Nephrol; 2020 Oct; 24(10):919-926. PubMed ID: 32577942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs.
    Satoh M; Hirose T; Nakayama S; Murakami T; Takabatake K; Asayama K; Imai Y; Ohkubo T; Mori T; Metoki H
    J Am Heart Assoc; 2020 Aug; 9(16):e015592. PubMed ID: 32794421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and factors associated to chronic kidney disease in older adults.
    Amaral TLM; Amaral CA; Vasconcellos MTL; Monteiro GTR
    Rev Saude Publica; 2019; 53():44. PubMed ID: 31066822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study.
    Chang Y; Ryu S; Choi Y; Zhang Y; Cho J; Kwon MJ; Hyun YY; Lee KB; Kim H; Jung HS; Yun KE; Ahn J; Rampal S; Zhao D; Suh BS; Chung EC; Shin H; Pastor-Barriuso R; Guallar E
    Ann Intern Med; 2016 Mar; 164(5):305-12. PubMed ID: 26857595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An association between body mass index and estimated glomerular filtration rate.
    Kawamoto R; Kohara K; Tabara Y; Miki T; Ohtsuka N; Kusunoki T; Yorimitsu N
    Hypertens Res; 2008 Aug; 31(8):1559-64. PubMed ID: 18971530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationships Between Metabolic Body Composition Status and Rapid Kidney Function Decline in a Community-Based Population: A Prospective Observational Study.
    Chu SC; Wang PH; Lu KY; Ko CC; She YH; Lee CC; Wu IW; Sun CY; Hsu HJ; Pan HC
    Front Public Health; 2022; 10():895787. PubMed ID: 35719641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study.
    Rebholz CM; Coresh J; Grams ME; Steffen LM; Anderson CA; Appel LJ; Crews DC
    Am J Nephrol; 2015; 42(6):427-35. PubMed ID: 26789417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
    Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
    Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.
    Cheng HT; Huang JW; Chiang CK; Yen CJ; Hung KY; Wu KD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1268-76. PubMed ID: 22337909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey Study.
    Arinsoy T; Deger SM; Ates K; Altun B; Ecder T; Camsari T; Serdengecti K; Suleymanlar G
    J Ren Nutr; 2016 Nov; 26(6):373-379. PubMed ID: 27641823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.